I'll raise this idea a second time - (this GT room's elephant?) | SRPT Message Board Posts

Sarepta Therapeutics Inc.

  SRPT website

SRPT   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  13793 of 13993  at  6/7/2019 3:22:23 PM  by

schmiggins

The following message was updated on 6/7/2019 3:24:20 PM.

 In response to msg 13792 by  schmiggins
view thread

Re: I'll raise this idea a second time - (this GT room's elephant?)

Well, I see "hardfocus" for one didn't read that last Gersbach article.

hardfocus: "$SRPT has a gene editing (GE) collaboration for over a year now at Duke, but problems with off-target editing has been a universal problem for all GE programs. Unlike $VRTX, $SRPT can go either way with G editing or insertion."

Gersbach raised that off target issue in his penultimate article a few months ago ... and reported that his group had solved it in his most recent report!

And so Vertex belatedly enters the editing field today. Whoopee. Saw no mentions of the fact that the two companies Vertex has bought into in the area are facing that off target issue and only our Gersbach has it beaten. Maybe the Picasso lover at DeadendPoints will look into that little detail one day.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 162
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board


About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...